LABCORP HOLDINGS INC.

Provides diagnostic lab testing and biopharma drug development services for healthcare clients.

LH | NYSE

Overview

Corporate Details

ISIN(s):: US5049221055
LEI:
Country:: United States of America
Address:: 358 S MAIN ST, 27215 BURLINGTON
Website:: https://www.labcorp.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Labcorp Holdings Inc. is a global life sciences company providing vital information to help doctors, hospitals, pharmaceutical companies, and patients make critical health decisions. The company operates through two primary segments: Diagnostics Laboratories and Biopharma Laboratory Services. The Diagnostics division offers a comprehensive menu of clinical laboratory tests, including specialty testing in areas like genetics and oncology, through an extensive network of patient service centers and direct-to-consumer platforms. The Biopharma segment provides end-to-end drug development solutions, including central laboratory services for clinical trials, nonclinical research, and real-world data analytics. By integrating its vast diagnostic data with its drug development expertise, Labcorp aims to accelerate medical innovation and improve health outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all LABCORP HOLDINGS INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for LABCORP HOLDINGS INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for LABCORP HOLDINGS INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Model Solution Co., Ltd. One-stop prototyping & low-volume production for IT, electronics, and medical hardware.	South Korea	417970
Modus Therapeutics Holding AB Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.	Sweden	MODTX
Moleculin Biotech, Inc. Developing therapies for hard-to-treat tumors (like AML) and viruses.	United States of America	MBRX
Molecure S.A. Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.	Poland	MOC
Moolec Science SA Uses Molecular Farming to grow animal proteins in plants for food, feed, and supplement industries.	United States of America	MLEC
MoonLake Immunotherapeutics Developing Nanobody therapies for inflammatory and immunologic diseases like psoriatic arthritis.	United States of America	MLTX
Mural Oncology plc Developing cytokine-based immunotherapies for difficult-to-treat cancers and solid tumors.	United States of America	MURA
Mural Oncology PLC Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.	Ireland	MURA
N2OFF, Inc. Sustainable agri-tech for food preservation, emissions reduction, and renewable energy.	United States of America	NITO
NANO MRNA Co.,Ltd. Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.	Japan	4571